e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Assessing respiratory function: QA and specific applications
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An
in vivo
comparison of two lung function systems
P. Munnik, P. Zanen, J. W. J. Lammers (Utrecht, Netherlands)
Source:
Annual Congress 2005 - Assessing respiratory function: QA and specific applications
Session:
Assessing respiratory function: QA and specific applications
Session type:
Thematic Poster Session
Number:
1151
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Munnik, P. Zanen, J. W. J. Lammers (Utrecht, Netherlands). An
in vivo
comparison of two lung function systems. Eur Respir J 2005; 26: Suppl. 49, 1151
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The lung in a box: ex vivo monitoring of donor lungs and clinical implications for lung preservation, repair and utilisation
Source: Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century
Year: 2021
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis
ex vivo
Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016
Year: 2017
Systematic differences in lung function outcomes in a new lung function lab.
Source: International Congress 2017 – Discussion of techniques and technologies in lung function
Year: 2017
How best to measure lung function in animals
Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease
Year: 2007
The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006
Potential therapeutic targets for lung repair during human
ex vivo
lung perfusion
Source: Eur Respir J, 55 (4) 1902222; 10.1183/13993003.02222-2019
Year: 2020
One lung ventilation: use of the impulse oscillation system to assess lung function in an animal model
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
Improving donor organ quality: the role of ex vivo lung perfusion
Source: International Congress 2019 – ME2 Improving donor organ quality: the role of ex vivo lung perfusion
Year: 2019
Exercise tests in determination functional system abilities for patients with complicated lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 11s
Year: 2005
LSC - 2017 - Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
Pro-fibrotic biomarkers in ex vivo lung tissue slices: A species comparison
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
Clinically validated markers of the extracellular matrix remodelling are altered by potential anti-fibrotic compounds in a human lung fibrosis ex vivo model
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018
Non-viral and viral gene transfer in ex vivo and in vivo lung models
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
In vivo imaging of NF-kB pathway in acute lung inflammation mouse model can predict a pharmacological response
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
In vitro and in vivo studies of nanoparticles and the lung
Source: International Congress 2014 – Nanomaterials and respiratory health
Year: 2014
The use of a murine model of brain death for mechanistic studies on treatment for donor lung injury
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro
Source: ERS Lung Science Conference 2018
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept